logo conference-reports

Kongressrapporter

Educational funding by logo MSD Oncology

ESMO-IO 2019 – Expert Commentary: What are the most practice-changing updates on immunotherapy for breast cancer?

Immuno-oncology is making an impact in triple negative breast cancer and will do more as diagnostics progress.
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis